ENDO 2025 Abstract
OR19-06 Safety and Effectiveness of Sulfonylureas for Pancreas-Cancer Induced Metabolic Dysregulation
Trial in peopleInterventions
The paper
Memorial Sloan Kettering Cancer Center
ENDO 2025 Abstract, 22 Oct 2025, CC BY-NC-ND
Presented at ENDO 2025
